Skip redundant pieces
KU Home   :   Life Span Home   :   Research Overview   :   Projects   :  Hormones and DNA Methylation in Autism

Hormones and DNA Methylation in Autism


This is a current project.


Description

We know that genes can be “turned on” and “turned off." We call this gene expression. One way that genes are “turned off” is through a process called DNA methylation.

We hypothesize that prenatal exposure to abnormal levels of hormones, or to toxins like Bisphenol A (BPA) that resemble hormones, can permanently alter gene expression in the brain during fetal development. If normally silenced or “turned-off” genes are switched on, the result may be abnormal nerve signaling which might result in autism symptoms.

Drs. Ellerbeck and Jacobson are investigating whether children with autism display abnormal DNA methylation patterns as compared to typically developing children


Project Administration

Co-Investigator: Dr. Kathryn Ellerbeck, MD, MPH, Center for Child Health and Development at the University of Kansas Medical Center

Principal Investigator: Dr. Jill Jacobson, MD, Children’s Mercy Hospital


Project Contact

Jordan Roberts, BA
Center for Child Health and Development
Mail Stop 4003
The University of Kansas Medical Center
3901 Rainbow Blvd.
Kansas City, KS 66160
Jroberts4@kumc.edu
913-588-0893


This is a project of:

Kansas Center for Autism Research and Training at the University of Kansas and Univeristy (K-CART 2008 Pilot Research Grantee)


Funded by:

The Univeristy of Kansas and the University of Kansas Medical Center

 

 

Participant Recruiting

This project is recruiting members of the greater Kansas City area. The study requires two visits to the Center for Child Health and Development. The first visit consists of a cognitive (IQ) assessment, medical exam and behavioral assessments. During the second visit parents complete questionnaires and behavioral rating scales and the child has approximately 2.5 tablespoons of blood drawn. The participants receive a $25 gift card to Target for each visit.


    Who is eligible for the study?

  • Children 4 or 5 years of age
  • Boys with diagnosed (or suspected) autism or atypical autism (PDD-NOS)
  • Boys and girls with no developmental problems

Because illness and/or medication might affect the blood tests, we are looking for healthy children who are not on daily medications.

For more information or to enroll in the study, please contact Study Coordinator Jordan Roberts at 913-588-0893.


Send corrections/comments/questions to lifespan@ku.edu.